Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

18

Revenue 2017

Takeda

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Takeda's 2013 sales performance.

Takeda

Pharma funding and M&A in 2020

Pharma funding and M&A in 2020

All this in the same year that Japan’s Takeda acquired Shire, making the combined entity one of the top ten pharmaceutical firms by revenue (and only the second non- American ... As we see with Takeda – and as we’ve seen with other industries,

In virtual meeting, CHMP backs Sanofi’s myeloma drug Sarclisa

In virtual meeting, CHMP backs Sanofi’s myeloma drug Sarclisa The anti-CD38 antibody is an option for patients who have been treated with at least two prior therapies, including BMS’ Revlimid (lenalidomide) and a proteasome inhibitor such as Takeda’s

AstraZeneca forms $2bn gene silencing pact with Silence Tx

AstraZeneca forms $2bn gene silencing pact with Silence Tx a smaller technical evaluation agreement with Takeda for preliminary work on an undisclosed drug target.

Takeda begins development of COVID-19 plasma therapy

Takeda begins development of COVID-19 plasma therapy According to Takeda, plasma-derived therapies have previously shown efficacy against other severe acute viral respiratory infections, making them a viable treatment option for use against COVID-19. ... said Rajeev Venkayya, president of Takeda’s

China backs use of Roche’s Actemra for coronavirus

China backs use of Roche’s Actemra for coronavirus In the meantime, Takeda and Alnylam have joined the companies working on drug treatments to tackle COVID-19 infections. ... Takeda has started developing a plasma-derived therapy – a polyclonal hyperimmune globulin called TAK-888 – that is intended

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
IGNIFI

We’re IGNIFI. An independent creative agency, we help spark and sustain successful brands for some of the biggest names in...

Latest intelligence

“Fake News” and Credibility in Medical Publishing
Natalie Yeadon from Impetus Digital shares her thoughts on fighting fake news in Pharma and healthcare....
Delivering true value: what does it mean for KAM in cancer care?
Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve...
Pharma M&A
Pharma funding and M&A in 2020
Why pharma M&A has continually bucked the trend...

Infographics